Cargando…

SARS-CoV-2 associated liver injury: a six-month follow-up analysis of liver function recovery

BACKGROUND AND AIMS: SARS-CoV-2 infection has raised the interest in clinical and paraclinical research worldwide, representing a public health issue since the beginning of 2020. Studies have established the variable, unpredictable character of COVID-19. Our main objective was to assess the liver fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Roman, Adina, Moldovan, Septimiu, Stoian, Mircea, Ţilea, Brînduşa, Dobru, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iuliu Hatieganu University of Medicine and Pharmacy 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694743/
https://www.ncbi.nlm.nih.gov/pubmed/36506606
http://dx.doi.org/10.15386/mpr-2347
_version_ 1784837881239437312
author Roman, Adina
Moldovan, Septimiu
Stoian, Mircea
Ţilea, Brînduşa
Dobru, Daniela
author_facet Roman, Adina
Moldovan, Septimiu
Stoian, Mircea
Ţilea, Brînduşa
Dobru, Daniela
author_sort Roman, Adina
collection PubMed
description BACKGROUND AND AIMS: SARS-CoV-2 infection has raised the interest in clinical and paraclinical research worldwide, representing a public health issue since the beginning of 2020. Studies have established the variable, unpredictable character of COVID-19. Our main objective was to assess the liver function of patients without pre-existing liver disease, diagnosed with SARS-CoV-2 associated liver injury in a 6-month follow-up study after discharge from hospital. METHODS: We conducted a prospective paraclinical and imagingstic follow-up study between 1st September 2020 and 30th April 2021 on patients without pre-existing liver disease previously diagnosed with SARS-CoV-2 associated liver injury who had been admitted in Mures County Clinical Hospital, Targu Mures, Romania. We followed up the patients ‘clinical and paraclinical datacharacteristics at index COVID-19 hospitalization and at T1 (6-month follow-up visit). RESULTS: We performed abdominal ultrasonography and laboratory examinations in 78 patients (mean age 45±10 years) hospitalized 6 months earlier for symptomatic COVID-19, with a male:female ratio of 1.3:1. Thirty patients (38.46%) were discharged at index COVID-19 hospitalization with abnormal liver function tests, while the rest presented paraclinical normalization at discharge and mean duration of liver injury of approximately 7 days. Follow-up examination revealed abnormal liver function tests in twenty-four patients, most of which presented with mild liver injury. All patients with severe COVID-19 at index hospitalization presented with abnormal liver function tests at follow-up examination. CONCLUSIONS: By performing a complete clinical and paraclinical 6-month follow-up study, with a specific focus on 34.6% of patients in which we noted a persistence of liver function tests abnormality, we could analyzse a possible long-term effect of SARS-CoV-2 infection over liver function and also raise awareness of liver function tests monitoring and therapeutic management in post COVID-19 patients. Long-term follow-up studies of COVID-19 multi-organ sequelae are therefore mandatory in order to improve the practice of consultant gastroenterologists.
format Online
Article
Text
id pubmed-9694743
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Iuliu Hatieganu University of Medicine and Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-96947432022-12-08 SARS-CoV-2 associated liver injury: a six-month follow-up analysis of liver function recovery Roman, Adina Moldovan, Septimiu Stoian, Mircea Ţilea, Brînduşa Dobru, Daniela Med Pharm Rep Original Research BACKGROUND AND AIMS: SARS-CoV-2 infection has raised the interest in clinical and paraclinical research worldwide, representing a public health issue since the beginning of 2020. Studies have established the variable, unpredictable character of COVID-19. Our main objective was to assess the liver function of patients without pre-existing liver disease, diagnosed with SARS-CoV-2 associated liver injury in a 6-month follow-up study after discharge from hospital. METHODS: We conducted a prospective paraclinical and imagingstic follow-up study between 1st September 2020 and 30th April 2021 on patients without pre-existing liver disease previously diagnosed with SARS-CoV-2 associated liver injury who had been admitted in Mures County Clinical Hospital, Targu Mures, Romania. We followed up the patients ‘clinical and paraclinical datacharacteristics at index COVID-19 hospitalization and at T1 (6-month follow-up visit). RESULTS: We performed abdominal ultrasonography and laboratory examinations in 78 patients (mean age 45±10 years) hospitalized 6 months earlier for symptomatic COVID-19, with a male:female ratio of 1.3:1. Thirty patients (38.46%) were discharged at index COVID-19 hospitalization with abnormal liver function tests, while the rest presented paraclinical normalization at discharge and mean duration of liver injury of approximately 7 days. Follow-up examination revealed abnormal liver function tests in twenty-four patients, most of which presented with mild liver injury. All patients with severe COVID-19 at index hospitalization presented with abnormal liver function tests at follow-up examination. CONCLUSIONS: By performing a complete clinical and paraclinical 6-month follow-up study, with a specific focus on 34.6% of patients in which we noted a persistence of liver function tests abnormality, we could analyzse a possible long-term effect of SARS-CoV-2 infection over liver function and also raise awareness of liver function tests monitoring and therapeutic management in post COVID-19 patients. Long-term follow-up studies of COVID-19 multi-organ sequelae are therefore mandatory in order to improve the practice of consultant gastroenterologists. Iuliu Hatieganu University of Medicine and Pharmacy 2022-10 2022-10-27 /pmc/articles/PMC9694743/ /pubmed/36506606 http://dx.doi.org/10.15386/mpr-2347 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License https://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Original Research
Roman, Adina
Moldovan, Septimiu
Stoian, Mircea
Ţilea, Brînduşa
Dobru, Daniela
SARS-CoV-2 associated liver injury: a six-month follow-up analysis of liver function recovery
title SARS-CoV-2 associated liver injury: a six-month follow-up analysis of liver function recovery
title_full SARS-CoV-2 associated liver injury: a six-month follow-up analysis of liver function recovery
title_fullStr SARS-CoV-2 associated liver injury: a six-month follow-up analysis of liver function recovery
title_full_unstemmed SARS-CoV-2 associated liver injury: a six-month follow-up analysis of liver function recovery
title_short SARS-CoV-2 associated liver injury: a six-month follow-up analysis of liver function recovery
title_sort sars-cov-2 associated liver injury: a six-month follow-up analysis of liver function recovery
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694743/
https://www.ncbi.nlm.nih.gov/pubmed/36506606
http://dx.doi.org/10.15386/mpr-2347
work_keys_str_mv AT romanadina sarscov2associatedliverinjuryasixmonthfollowupanalysisofliverfunctionrecovery
AT moldovanseptimiu sarscov2associatedliverinjuryasixmonthfollowupanalysisofliverfunctionrecovery
AT stoianmircea sarscov2associatedliverinjuryasixmonthfollowupanalysisofliverfunctionrecovery
AT tileabrindusa sarscov2associatedliverinjuryasixmonthfollowupanalysisofliverfunctionrecovery
AT dobrudaniela sarscov2associatedliverinjuryasixmonthfollowupanalysisofliverfunctionrecovery